KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 128 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,203 | -58.3% | 134,624 | -14.1% | 0.00% | – |
| Q2 2023 | $383,942 | -56.2% | 156,711 | -44.1% | 0.00% | – |
| Q1 2023 | $877,073 | +0.5% | 280,215 | +125.9% | 0.00% | – |
| Q4 2022 | $873,115 | -22.0% | 124,022 | -4.6% | 0.00% | – |
| Q3 2022 | $1,119,000 | -69.8% | 130,016 | -71.0% | 0.00% | – |
| Q2 2022 | $3,707,000 | -35.2% | 448,316 | +30.3% | 0.00% | – |
| Q1 2022 | $5,719,000 | +82.2% | 344,107 | +83.3% | 0.00% | – |
| Q4 2021 | $3,138,000 | +1145.2% | 187,758 | +343.9% | 0.00% | – |
| Q1 2021 | $252,000 | +59.5% | 42,301 | +39.8% | 0.00% | – |
| Q4 2020 | $158,000 | +97.5% | 30,268 | +82.7% | 0.00% | – |
| Q3 2020 | $80,000 | -88.0% | 16,568 | -87.1% | 0.00% | – |
| Q2 2020 | $664,000 | +1255.1% | 128,200 | +1030.9% | 0.00% | – |
| Q1 2020 | $49,000 | – | 11,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |